Unternehmensprofil · Healthcare

Joincare Pharmaceutical Group Industry Co Ltd

600380 · Shanghai
Land / Region
China
Börsengang
9. Mai 2001
Mitarbeiter
13.575
Buffett Score
76/100
Stark
Marktkapitalisierung18,59 Mrd. CN¥
Umsatz (TTM)13,9 Mrd. CN¥
EBITDA3,4 Mrd. CN¥
Nettomarge8,62 %
ROE10,44 %
KGV (TTM)15,63
Erwartetes KGV22,68
EPS0,65 CN¥
Dividendenrendite2,22 %
52-Wochen-Spanne9,08 CN¥ – 12,85 CN¥

Daten von EODHD, dargestellt in der Berichtswährung; nur zu Informationszwecken, keine Anlageberatung.

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such as mycoplasma pneumoniae IgM antibody test and antinuclear antibody test kit; OTC products which includes Taitai and Jingxin oral liquid, Eagle's American ginseng tea, and YikeTie; and biologics comprising tocilizumab and mouse nerve growth factor injection. The company was founded in 1992 and is headquartered in Shenzhen, China.

Geschichte

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.

Branchenposition

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.

Noch keine Analysen zu dieser Aktie in Ihrer Sprache.